The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

Varanasi: An awareness programme was organised by Sathiya Kendra of the Institute of Medical Sciences (IMS), Banaras Hindu ...

Merck MRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings ...

HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...

Immunization has saved an estimated 150 million lives since 1974 — six lives every minute. Vaccination accounts for 40 ...

Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...

Merck maintained its 2025 full-year revenue guidance of $64.1 billion to $65.6 billion, representing 1% to 3% growth excluding foreign exchange impacts. EPS guidance was adjusted to $8.82 to $8.97, ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

The US has made some progress in the fight against some cancers, but prevention for others isn’t increasing. According to a ...